Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386693 · ClinicalTrials.gov registry record
Surgical Outcomes Following Neurectomy Based Upon Response to Local Anesthetic Injection in Chronic Groin Pain
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 10
- Enrollment target
NCT05386693: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT05386693 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05386693 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The management of chronic pain after inguinal hernia surgery presents unique challenges. Ilioinguinal nerve blocks are often used in the initial treatment of this disease. This can often be followed by surgery, including neurectomy and/or hernia mesh removal. In an effort to identify preoperative predictors of postoperative outcomes following these surgical interventions the investigators devised a study to prospectively evaluate and correlate a patients pre-operative response to an ilioinguinal nerve block with their post-operative outcomes following surgery for chronic groin pain after inguinal hernia surgery.
Primary Outcome
Pain as measured with the Visual Analogue Scale (VAS) using a scale of 0 to 100; with 0 being the least amount of pain and 100 being the most amount of pain.
Interventions
- PROCEDURE Ilioinguinal nerve block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2024-03-25 |
Why NCT05386693 stopped before completion
NCT05386693 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ilioinguinal nerve block is the first listed.
NCT05386693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05386693 about?
NCT05386693 is a clinical study titled "Surgical Outcomes Following Neurectomy Based Upon Response to Local Anesthetic Injection in Chronic Groin Pain". The management of chronic pain after inguinal hernia surgery presents unique challenges. Ilioinguinal nerve blocks are often used in the initial treatment of this disease. This can often be followed by surgery, including neurectomy and/or hernia mesh removal. In an effort to identify preoperative pr...
What is the current status of trial NCT05386693?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2022-04-20. Estimated completion is 2024-03-25.
What interventions are being tested in trial NCT05386693?
The interventions under investigation include: Ilioinguinal nerve block (PROCEDURE).
Who is sponsoring clinical trial NCT05386693?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI